The leukocytes expressing DARPP-32 are reduced in patients with schizophrenia and bipolar disorder
about
Biomarkers in schizophrenia: A focus on blood based diagnostics and theranosticsConvergent functional genomic studies of ω-3 fatty acids in stress reactivity, bipolar disorder and alcoholism.Monocyte and lymphocyte activation in bipolar disorder: a new piece in the puzzle of immune dysfunction in mood disorders.The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder.Beyond the dopamine receptor: regulation and roles of serine/threonine protein phosphatases.DARPP-32, Jack of All Trades… Master of Which?Abnormal activity of the MAPK- and cAMP-associated signaling pathways in frontal cortical areas in postmortem brain in schizophrenia.The mRNA Expression Status of Dopamine Receptor D2, Dopamine Receptor D3 and DARPP-32 in T Lymphocytes of Patients with Early PsychosisBiomarker investigations related to pathophysiological pathways in schizophrenia and psychosis.Meta-analysis of lymphocytes in schizophrenia: clinical status and antipsychotic effects.Feedback regulation mediated by Bcl-2 and DARPP-32 regulates inositol 1,4,5-trisphosphate receptor phosphorylation and promotes cell survival.Circulating T lymphocyte subsets, cytokines, and immune checkpoint inhibitors in patients with bipolar II or major depression: a preliminary study.The role of dopaminergic signalling during larval zebrafish brain development: a tool for investigating the developmental basis of neuropsychiatric disorders.Use of cerebrospinal fluid biomarkers in clinical trials for schizophrenia and depression.Novel biomarkers for bipolar disorder.Microarray profiling of long non-coding RNAs associated with idiopathic pulmonary arterial hypertension.Employing proteomics to unravel the molecular effects of antipsychotics and their role in schizophrenia.LC-MSE for Qualitative and Quantitative Proteomic Studies of Psychiatric Disorders.Potential for targeting dopamine/DARPP-32 signaling in neuropsychiatric and neurodegenerative disorders.
P2860
Q28068871-FAA34FB5-1050-4F09-ACB9-3D2E3C620766Q30511829-49AB4982-514C-46BE-93BB-3E8384C6F5ECQ33359759-49802BA8-D523-49F1-A8F9-83F31752E25DQ34088944-C0C1541E-48C3-4E39-BBED-C3FB75C6D806Q35182543-9BEC3D9B-5180-4FA6-8A99-5C5BA3AA933EQ35201971-085DD389-C886-4319-AB3C-D9E587ECD5CFQ35760215-F0E44F9A-228D-4E0E-A4A7-46B1B1D75803Q36324583-CC7817A8-B18B-42E6-AEC3-4879CEA1A291Q36955877-C7D48C85-00DB-4346-B939-D0EFC41D07BDQ37275549-B501D422-500B-4BE9-A414-BF56C8DA59DDQ37519743-0E64C28A-7A67-43E7-8AC8-54C07743D2F4Q37578777-B8CA3E1F-E586-4F8A-97E2-5423F26018D3Q37880098-D1A1D4BD-6BAE-4658-A726-4E6732131EEBQ37980501-0C366BD1-EEB1-4987-A9CA-9F26E54C4D6CQ38093255-D1BC7F71-D019-491F-94C6-DAEF3F096445Q38432710-A1074A47-F020-40AB-843C-4899B4E99D31Q38672722-30DABA07-ABAC-4341-ABD7-356BC7DD710FQ38869527-15F3234E-268A-4F31-9417-C4148BE63629Q39067400-97AFEEC4-DFA4-4B00-B080-87C9577DAFEF
P2860
The leukocytes expressing DARPP-32 are reduced in patients with schizophrenia and bipolar disorder
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
The leukocytes expressing DARP ...... zophrenia and bipolar disorder
@ast
The leukocytes expressing DARP ...... zophrenia and bipolar disorder
@en
The leukocytes expressing DARP ...... zophrenia and bipolar disorder
@nl
type
label
The leukocytes expressing DARP ...... zophrenia and bipolar disorder
@ast
The leukocytes expressing DARP ...... zophrenia and bipolar disorder
@en
The leukocytes expressing DARP ...... zophrenia and bipolar disorder
@nl
prefLabel
The leukocytes expressing DARP ...... zophrenia and bipolar disorder
@ast
The leukocytes expressing DARP ...... zophrenia and bipolar disorder
@en
The leukocytes expressing DARP ...... zophrenia and bipolar disorder
@nl
P2093
P50
P921
P1476
The leukocytes expressing DARP ...... zophrenia and bipolar disorder
@en
P2093
A G A Barros
K C L Torres
R Nicolato
P304
P356
10.1016/J.PNPBP.2008.10.020
P407
P577
2008-11-08T00:00:00Z